Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment?

Clin Infect Dis. 2020 Sep 4;ciaa1282. doi: 10.1093/cid/ciaa1282. Online ahead of print.
No abstract available